Who backs Outpace Bio?
20 investors| Investor | Type |
|---|---|
| Mana Ventures | Venture capital |
| Gaingels | Venture capital |
| RA Capital Management | Asset manager |
| Abstract Ventures | Venture capital |
| Qiming Venture Partners | Venture capital |
| Alexandria Venture Investments | Other |
| Qatar Investment Authority | Asset manager |
| ATEL Capital Group | Asset manager |
| Playground Global | — |
| Bristol-Myers Squibb | — |
| + 10 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Outpace Bio investors
20 investors are on record for Outpace Bio, including Mana Ventures, Gaingels, RA Capital Management and Abstract Ventures. By type, the record holds 5 venture capital firms and 3 asset managers. The Series B in Jul 2024 drew 15 investors.
Free account
More of Outpace Bio with a free account
- ·The complete investor list: 20 names
- ·Watch Outpace Bio: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 20 firms already write checks for companies like Outpace Bio in discovery tools (healthcare). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View